Genes, Drugs and Stem Cells – Novel Therapies

Course Overview

Offered by Imperial College London, the MSc Genes, Drugs and Stem Cells – Novel Therapies provides a comprehensive postgraduate education in biological sciences. Based in Islington, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time structure. Gain proficiency in translational research and explore a range of next-generation therapies on this Master’s course. You'll acquire transferable skills in translational research, exploring the steps required to progress novel therapies from bench-to-bedside and towards drug licensing. You'll also build your knowledge of ethical and regulatory legislation, commercialisation strategies, and intellectual property and patent protection. International tuition fees are £47,300 per year, home/UK fees are £8,150 per year, and a minimum IELTS score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with 90% student satisfaction rating, a median graduate salary of £33,500 within three years, and a 95% continuation rate.

What You'll Learn

Tuition Fees & Funding

Fees shown are for current entry. Fees may increase annually in line with inflation.

Graduate Outcomes

Frequently Asked Questions